Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_15-cv-05992/USCOURTS-cand-5_15-cv-05992-0/pdf.json

Nature of Suit Code: 850
Nature of Suit: Securities, Commodities, Exchange
Cause of Action: 15:78m(a) Securities Exchange Act

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

MATTHEW SCIABACUCCHI, individually and

on Behalf of All Others Similarly Situated,

Plaintiff,

 v.

KALOBIOS PHARMACEUTICALS, INC., and

MARTIN SHKRELI,

Defendant. /

No. C-15-5992 CRB

ORDER

Upon representation of defendant KaloBios Pharmaceutical, Inc. Suggestion of Bankruptcy

and GOOD CAUSE APPEARING THEREFOR:

There appears to be no further reason at this time to maintain the file as an open one for

statistical purposes. Accordingly, the Clerk is instructed to submit a JS-6 form to the Administrative

Office.

Nothing contained in this minute entry shall be considered a dismissal or disposition of this

action, and should further proceedings in this litigation become necessary or desirable, any party

may initiate it in the same manner as if this order had not been entered.

IT IS SO ORDERED.

DATE: March 18, 2106

 

CHARLES R. BREYER

UNITED STATES DISTRICT JUDGE

Case 5:15-cv-05992-EJD Document 8 Filed 03/21/16 Page 1 of 1